Filter
96
Text search:
vaccine
candidates
Featured
Recommendations
11
New Publications
14
Language
Document type
No document type
27
Studies & Reports
23
Guidelines
17
Fact sheets
12
Manuals
4
Strategic & Response Plan
4
Resource Platforms
3
Videos
3
Online Courses
2
Situation Updates
1
Countries / Regions
Global
6
Russia
5
East and Southern Africa
4
West and Central Africa
4
Middle East and North Africa
4
Africa
3
South Sudan
2
Kenya
2
China
2
Ukraine
2
Sierra Leone
1
Liberia
1
Nigeria
1
Uganda
1
Philippines
1
Germany
1
Turkey
1
Syria
1
Tanzania
1
Rwanda
1
South Africa
1
Brazil
1
North Macedonia
1
Latin America and the Carribbean
1
Asia
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
24
Clinical Guidelines
10
Public Health
4
Key Resources
3
Women & Child Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
40
TB
9
NTDs
6
Rapid Response
4
HIV
4
Polio
3
AMR
3
Ebola & Marburg
2
Zika
2
Global Health Education
2
Conflict
1
Pharmacy
1
Health Financing Toolbox
1
NCDs
1
2.0 Rapid Response
1
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmente
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19
...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pa
...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisat
...
COVID-19 Vaccine Resource Center
recommended
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح
...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
AstraZeneca-SKBio in South Korea and Serum Institute of India
